Heron Therapeutics, Inc.

HRTX XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

86M

Short interest (Jul 15)

22.5%

Net Short (Jul 27 ): 0.0%

Borrow Fee

1.10%

↑ 5.7%

Available Shares

↓ 41.9%

Price Chart

Company Overview

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0000818033

Asset Type: CS

Market Data

Market Cap: $86,273,536

Employees: 128

Status: Active

Short Interest

Current Borrow Fee 1.10%

Range: 1.09% - 1.19%

Available Shares 1M

Range: 900K - 1.2M

Recent Changes

Fee Change: ↓ 9.1%

Available Change: ↓ 36.1%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime